The Indian Drug Manufacturers' Association (IDMA) and the Association of Pharmaceutical Analysts (APA) will jointly organise the 12th Pharmaceutical Analysts' Convention (PAC) 2009 on October 9 & 10 in Mumbai.

The main theme of this year's convention is 'The Analyst: An Agent To Enhance Excellence'. US FDA and UK MHRA CEOs have been invited to make presentations at this prestigious convention.

Some of the topics proposed to be covered at PAC 2009 are as under: Role of Analyst in compiling an excellent CTD; Vendor Approval for starting material; Risk Management; Effective OOS Investigation; Tracking & Trending impurities; Reference substances; and Microbiological tests and assays; Setting specifications for modified release dosage forms; Quality audit trail-ready at any time; Patenting analytical techniques, Impurity references substances-procurement, maintenance and use; and Speed 2 productivity in impurity profiling and routine analysis.

The two-day event will be an excellent opportunity for the analysts working in the pharmaceutical industry, R&D Institutions, government laboratory and approved testing laboratories.

Major speakers of the convention include: Dr Vijay Kshirsagar, executive vice-president, corporate quality assurance & regulatory affairs, Unichem Lab Ltd; R Raghunandanan, pharma consultant; SM Mudda, executive director, technical & operations, Micro Labs Ltd; Vivek Dhyani, application specialist, Agilent Technology; Dr Gopakumar Nair, CEO, Gopakumar Nair Associates; Dr Saranjit Singh, professor & head, department of pharmaceutical analysis, and dean, NIPER; and Premnath Shenoy, AstraZeneca, Bangalore.